TissueLabs
TissueLab’s mission is to produce synthetic tissues and organs for therapeutic applications.
TissueLabs has raised €739k across 1 funding round from 2 investors, most recently a Pre-Seed round in Mar 2024. Based in Manno, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€739k
€739,167
Funding rounds
1
Investors
2
distinct backers
Active since
2024-03
latest 2024-03
Funding by year
EUR raised per yearTissueLabs — funding by year — interactive chart.
Data table
| TissueLabs — funding by year | |
|---|---|
| 2024 | €739k |
Signals
High confidenceRaise-next likelihood4
base rate 24% for Pre-Seed
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-03-22 | Pre-Seed | €739k | Mergus Ventures,MIT Angels | View deal → |
Investors
2Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData